• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    27 Stocks Moving in Monday's Pre-Market Session

    3/1/22 5:47:58 AM ET
    $AREB
    $ATXI
    $AVGR
    $AVIR
    Plastic Products
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AREB alert in real time by email

    Gainers

    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) rose 28.6% to $1.71 in pre-market trading. American Rebel recently reported closing of $10.5 million public offering.
    • VEON Ltd. (NASDAQ:VEON) rose 27.5% to $0.6570 in pre-market trading. VEON reported its intention to share access to its Augmented Intelligence Platform capabilities and know-how with the international mobile operator community.
    • GBS Inc. (NASDAQ:GBS) rose 26.1% to $0.58 in pre-market trading after declining around 9% on Monday.
    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) rose 19.2% to $3.10 in pre-market trading after jumping 68% on Monday.
    • Mullen Automotive, Inc. (NASDAQ:MULN) rose 17.2% to $1.98 in pre-market trading after gaining over 145% on Monday. Mullen Automotive recently announced progress on solid-state polymer battery pack development.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) shares rose 15.3% to $0.6809 in pre-market trading.
    • Ucommune International Ltd (NASDAQ:UK) shares rose 12% to $0.4550 in pre-market trading after dipping around 17% on Monday.
    • Supernova Partners Acquisition Company II, Ltd. (NYSE:SNII) rose 11.5% to $11.05 in pre-market trading after gaining over 6% on Monday.
    • 3D Systems Corporation (NYSE:DDD) rose 11.2% to $19.84 in pre-market trading after the company reported better-than-expected Q4 results.
    • Avinger, Inc. (NASDAQ:AVGR) rose 11.1% to $0.2888 in pre-market trading. Avinger recently reported successful completion of first cases with Lightbox 3 next generation imaging console.
    • Editas Medicine, Inc. (NASDAQ:EDIT) rose 11% to $19.00 in pre-market trading as the company reported favorable decision from U.S. Patent and Trademark Office in CRISPR patent interference.
    • NextDecade Corporation (NASDAQ:NEXT) rose 10.3% to $3.74 in pre-market trading after surging 21% on Monday.
    • Secoo Holding Limited (NASDAQ:SECO) rose 8.9% to $0.4353 in pre-market trading after climbing around 22% on Monday.
    • Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) rose 8.4% to $6.87 in pre-market trading following upbeat Q4 results.
    • Puhui Wealth Investment Management Co., Ltd. (NASDAQ:PHCF) rose 7% to $1.37 in pre-market trading after climbing over 18% on Monday.


    Losers

    • GoodRx Holdings, Inc. (NASDAQ:GDRX) shares fell 30.9% to $18.94 in pre-market trading after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 14.6% to $0.1862 in pre-market trading after jumping 45% on Monday.
    • Vroom, Inc. (NASDAQ:VRM) fell 13.7% to $5.25 in pre-market trading after reporting a wider-than-expected Q4 loss.
    • Lucid Group, Inc. (NASDAQ:LCID) fell 13.2% to $25.15 in pre-market trading after the company reported worse-than-expected Q4 sales results and cut FY22 production guidance.
    • PubMatic, Inc. (NASDAQ:PUBM) shares fell 11.4% to $27.10 in pre-market trading after the company issued Q1 sales guidance below estimates.
    • DSS, Inc. (NYSE:DSS) shares fell 11% to $0.5035 in pre-market trading after jumping 47% on Monday.
    • Motus GI Holdings, Inc. (NASDAQ:MOTS) shares fell 11% to $0.3137 in pre-market trading. Motus GI recently received FDA clearance to market its Pure-Vu EVS System.
    • Groupon, Inc. (NASDAQ:GRPN) shares fell 10.9% to $19.36 in pre-market trading after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
    • Cyren Ltd. (NASDAQ:CYRN) fell 9.1% to $5.32 in pre-market trading.
    • Vital Farms, Inc. (NASDAQ:VITL) fell 7.7% to $13.15 in pre-market trading. Vital Farms is expected to release Q4 results on March 10.
    • Novavax, Inc. (NASDAQ:NVAX) fell 7.6% to $77.00 in pre-market trading after the company reported Q4 EPS and sales results were down year over year.
    Get the next $AREB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AREB
    $ATXI
    $AVGR
    $AVIR

    CompanyDatePrice TargetRatingAnalyst
    VEON Ltd. ADS
    $VEON
    4/16/2026$74.00Buy
    Rothschild & Co Redburn
    Vital Farms Inc.
    $VITL
    4/8/2026$16.00Buy → Hold
    TD Cowen
    Vital Farms Inc.
    $VITL
    3/27/2026$35.00 → $26.00Outperform
    Telsey Advisory Group
    Lucid Group Inc.
    $LCID
    3/18/2026$17.00Buy
    Citigroup
    NextDecade Corporation
    $NEXT
    3/5/2026$7.00 → $6.00Hold
    TD Cowen
    Lucid Group Inc.
    $LCID
    3/4/2026$10.00Underperform
    BofA Securities
    Vital Farms Inc.
    $VITL
    2/27/2026$24.00Overweight → Equal-Weight
    Morgan Stanley
    GoodRx Holdings Inc.
    $GDRX
    2/27/2026Overweight → Neutral
    Analyst
    More analyst ratings

    $AREB
    $ATXI
    $AVGR
    $AVIR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AREB
    $ATXI
    $AVGR
    $AVIR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VEON Boosts Accessibility for Investors by Waiving Depositary Service Fees on American Depositary Shares

    Dubai and New York, April 24, 2026 – VEON Ltd. (NASDAQ:VEON), a global digital operator (the "Company" or "VEON"), announces that, effective January 1, 2026, BNY Mellon will not collect depositary service fees ("DSF") from investors that hold VEON's American Depositary Shares ("ADSs"). The suspension of DSF charges for investors effectively reduces the cost of ownership by USD 0.05 per ADS per year and enhances accessibility for both existing and prospective investors. "VEON's steps to reduce the cost of ownership of ADSs and introduce a capital allocation policy that targets to return at least USD 100 million annually through share buybacks are both responses to our ongoing dialogue with i

    4/24/26 2:47:34 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    AdRoll and PubMatic Enable Agent-Powered Deal Troubleshooting via MCP Integration

    Integration leverages Model Context Protocol to connect demand- and supply-side platforms in a unified diagnostic workflow SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- AdRoll, an AI-powered multi-channel advertising platform, today announced a partnership with PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, to demonstrate how AI can diagnose campaign delivery issues across demand-side and supply-side platforms. Through this integration, AdRoll uses the Model Context Protocol (MCP) to query PubMatic's agentic diagnostics in a single agentic workflow, allowing campaign configuration and exchange-level diagnostics to be evaluate

    4/23/26 9:00:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    Vital Farms to Report First Quarter 2026 Financial Results on May 7, 2026

    Vital Farms (NASDAQ:VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, will report financial results for the first quarter ended March 29, 2026, on Thursday, May 7, 2026, before market open. Vital Farms will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. Alternatively, participants may access the live webcast on the Vital Farms Investor Relations website at https://investors.vitalfarms.com under "Events." The webcast will be archived for 30 days. About Vital Farms

    4/23/26 8:30:00 AM ET
    $VITL
    Packaged Foods
    Consumer Staples

    $AREB
    $ATXI
    $AVGR
    $AVIR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Napoli Silvio

    4 - Lucid Group, Inc. (0001811210) (Issuer)

    4/17/26 4:12:45 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    SEC Form 3 filed by new insider Napoli Silvio

    3 - Lucid Group, Inc. (0001811210) (Issuer)

    4/17/26 4:08:07 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Walker Robert Edward

    4 - NOVAVAX INC (0001000694) (Issuer)

    4/16/26 6:13:00 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AREB
    $ATXI
    $AVGR
    $AVIR
    SEC Filings

    View All

    GoodRx Holdings Inc. filed SEC Form 8-K: Leadership Update

    8-K - GoodRx Holdings, Inc. (0001809519) (Filer)

    4/24/26 4:29:26 PM ET
    $GDRX
    EDP Services
    Technology

    Amendment: SEC Form S-1/A filed by DSS Inc.

    S-1/A - DSS, INC. (0000771999) (Filer)

    4/24/26 4:05:48 PM ET
    $DSS
    Containers/Packaging
    Consumer Discretionary

    SEC Form 6-K filed by Ucommune International Ltd

    6-K - Ucommune International Ltd (0001821424) (Filer)

    4/24/26 4:00:02 PM ET
    $UK
    Real Estate

    $AREB
    $ATXI
    $AVGR
    $AVIR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cyr William B. bought $98,325 worth of shares (4,750 units at $20.70), increasing direct ownership by 156% to 7,794 units (SEC Form 4)

    4 - Vital Farms, Inc. (0001579733) (Issuer)

    3/4/26 5:30:03 PM ET
    $VITL
    Packaged Foods
    Consumer Staples

    Large owner Hanwha Aerospace Co., Ltd. bought $9,399,378 worth of shares (1,651,971 units at $5.69) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/15/25 7:12:58 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Large owner Hanwha Aerospace Co., Ltd. bought $5,742,414 worth of shares (932,598 units at $6.16) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/10/25 8:15:10 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AREB
    $ATXI
    $AVGR
    $AVIR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on VEON with a new price target

    Rothschild & Co Redburn initiated coverage of VEON with a rating of Buy and set a new price target of $74.00

    4/16/26 8:05:08 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    Vital Farms downgraded by TD Cowen with a new price target

    TD Cowen downgraded Vital Farms from Buy to Hold and set a new price target of $16.00

    4/8/26 8:30:56 AM ET
    $VITL
    Packaged Foods
    Consumer Staples

    Telsey Advisory Group reiterated coverage on Vital Farms with a new price target

    Telsey Advisory Group reiterated coverage of Vital Farms with a rating of Outperform and set a new price target of $26.00 from $35.00 previously

    3/27/26 7:58:39 AM ET
    $VITL
    Packaged Foods
    Consumer Staples

    $AREB
    $ATXI
    $AVGR
    $AVIR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by DSS Inc.

    SC 13D/A - DSS, INC. (0000771999) (Subject)

    12/12/24 9:56:52 PM ET
    $DSS
    Containers/Packaging
    Consumer Discretionary

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREB
    $ATXI
    $AVGR
    $AVIR
    Leadership Updates

    Live Leadership Updates

    View All

    Lucid Names Global Industrial Leader Silvio Napoli as Next Chief Executive Officer to Accelerate Growth, Profitability and Value Creation

    Silvio Napoli, formerly Chairman and Chief Executive Officer of Schindler Group, to join Lucid as next Chief Executive OfficerInterim Chief Executive Officer Marc Winterhoff will continue as Chief Operating Officer upon Napoli assuming the roleNEWARK, Calif., April 14, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced software-defined vehicles and technologies, today announced that Silvio Napoli will be Lucid's next Chief Executive Officer (CEO) and will join Lucid's Board of Directors. Mr. Napoli is currently based in Switzerland and will be relocating to the U.S. Interim Chief Executive Officer Marc Winterhoff will serve as Lucid's Chief Operating Off

    4/14/26 7:00:00 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    VEON Announces 2026 AGM and Board Nominees

    Dubai and New York, March 31, 2026 – VEON Ltd. (NASDAQ:VEON), a global digital operator, ("VEON" or the "Company"), today announced that its Board of Directors (the "Board") has set the date for the Company's 2026 Annual General Meeting of Shareholders (the "AGM") for May 11, 2026 at 12:00 Gulf Standard Time. The record date for the AGM has been set for March 31, 2026. The Board and its Nomination Committee have recommended VEON's seven current Board members for re-election at the AGM. The recommended nominees are Augie K Fabela II, Andrei Gusev, Sir Brandon Lewis, Duncan Perry, the 70th U.S. Secretary of State Michael R. Pompeo, Michiel Soeting, and the Company's Chief Executive Officer Ka

    3/31/26 8:36:29 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AREB
    $ATXI
    $AVGR
    $AVIR
    Financials

    Live finance-specific insights

    View All

    Vital Farms to Report First Quarter 2026 Financial Results on May 7, 2026

    Vital Farms (NASDAQ:VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, will report financial results for the first quarter ended March 29, 2026, on Thursday, May 7, 2026, before market open. Vital Farms will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. Alternatively, participants may access the live webcast on the Vital Farms Investor Relations website at https://investors.vitalfarms.com under "Events." The webcast will be archived for 30 days. About Vital Farms

    4/23/26 8:30:00 AM ET
    $VITL
    Packaged Foods
    Consumer Staples

    Groupon Announces Date for First Quarter 2026 Financial Results

    Chicago, Illinois--(Newsfile Corp. - April 23, 2026) - Groupon, Inc. (NASDAQ:GRPN) announced today that it intends to release the company's first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Friday, May 8, 2026. Investors may submit questions by emailing [email protected] webcast of the conference call can be accessed live at investor.groupon.com. A replay of the webcast will be available through the same link following the conference call, along with other published materials.About Groupon Groupon (www.groupon.com) (NASDAQ:GRPN) is a trusted loc

    4/23/26 7:00:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    PubMatic Reports Preliminary First Quarter 2026 Revenue and Adjusted EBITDA Results Above Guidance; Announces Global CRO Search

    PubMatic, Inc. (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, today reported preliminary unaudited results for revenue and Adjusted EBITDA in the first quarter of 2026, and announced leadership transitions to position the company for its next phase of growth. Strong Q1 Results Reflect Business Momentum The Company expects first quarter 2026 revenue to be approximately $62.4 million, with approximately $2.5 million in adjusted EBITDA. These figures exceed PubMatic's previously-issued first quarter 2026 guidance of $58.0 million to $60.0 million in revenue and $(0.5) to $1.0 million in adjusted EBITDA. These results highlight strong execu

    4/22/26 5:00:00 PM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology